Education
About Us
Working with TipRanks
Follow Us
Maha Katabi Insider Profile
11 Followers
Maha Katabi, Director at Vera Therapeutics, holds 2.79M shares in Vera Therapeutics (Ticker: VERA), holds 0.00 shares in RayzeBio, Inc. (Ticker: RYZB), holds 3.76M shares in Jade Biosciences (Ticker: JBIO). Most recently, Maha Katabi Sold ― shares of Vera Therapeutics on Mar 25, 2024 for an estimated value of $34.10M.
Profitable Transactions
3 out of 4 Profitable Transactions
Average Return
+14.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Maha Katabi holds in companies
Most Profitable Insider Trade
The most profitable trade made by Maha Katabi
Maha Katabi's Trading History
Vera Therapeutics
Mar 25, 2024
Director
Informative Sell
34.10M
$112.93M
Jade Biosciences
Jul 06, 2021
Director, Ten Percent Owner
Informative Buy
5.00M
$53.07M
RayzeBio, Inc.
Feb 27, 2024
―
Uninformative Sell
151.22M
$0.00
List of latest transactions for each holding click on a transaction to see Maha Katabi's performance on stock
You May Also Like
Maha Katabi insider profile FAQ
What is the percentage of profitable transactions made by Maha Katabi?
The percentage of profitable transactions made by Maha Katabi is 75%.
What is the average return per transaction made by Maha Katabi?
The average return per transaction made by Maha Katabi is 14.30%.
What stocks does Maha Katabi hold?
Maha Katabi holds: VERA, JBIO, RYZB stocks.
What was Maha Katabi’s latest transaction?
Maha Katabi latest transaction was an Informative Sell of $34.10M.
What was Maha Katabi's most profitable transaction?
Maha Katabi’s most profitable transaction was an Informative Sell of VERA stock on March 25, 2024. The return on the trade was 34.50%.
What is Maha Katabi's role in Vera Therapeutics?
Maha Katabi's role in Vera Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.